We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPRA:NASDAQOpera Limited analysis

Data as of Sep 17, 2026 - not real-time

Latest price
$18.41
Risk: high
8/10High risk

Summary

Opera Limited is priced at $18.41, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 10.2%. RSI sits at 45.1, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $17.35 up to resistance at $20.03.
On valuation the read is undervalued — earnings multiple of 13.3 versus a 15.6 sector average, below the peer group. Analyst price targets sit 42.8% above the current price. Revenue is growing at 24.6% on a 18.5% profit margin. The 4.35% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 35.8%, a beta of 1.55 and a maximum drawdown of 42.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top market events

  • Opera Limited NASDAQ:OPRA shares fell 5.48% in pre-market trading after the browser and AI agent company reported...
  • In August 2026, Opera Limited reported past second-quarter 2026 results showing sales of US$178.
  • Revenue increased 25% year-over-year to $178.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 16.50
  • MACD momentum is negative
  • 30-day price change of -10.2%

Medium term

1–3 years

Positive

Model confidence4/104 out of 10

Key factors

  • P/E of 13.3 versus sector average of 15.6
  • Trading above the 200-day average of 16.50
  • Analyst targets imply +42.8% versus the current price

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 13.3 versus sector average of 15.6
  • Analyst targets imply +42.8% versus the current price
  • Profit margin of 18.5% is healthy

Key metrics

Financial health

Revenue Growth24.60%
Profit Margin18.55%
P/E Ratio13.3
ROE12.86%
ROA6.22%
Debt/Equity0.79
P/B Ratio1.6
Op. Cash Flow$133.0M
Free Cash Flow$111.7M
Industry P/E15.6

Technical analysis

TrendNeutral
RSI45.1
Support$17.35
Resistance$20.03
MA 20$18.67
MA 50$19.16
MA 200$16.50
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Fair Value$42.82
Target Price$26.29
Upside/Downside42.78%
GradeUndervalued
TypeBlend
Dividend Yield4.35%

Risk assessment

Beta1.55
Volatility35.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.